Loreto Martínez‐González

Author

Centro de Investigaciones Biológicas Margarita Salas ORCID

Also Known As

L. Martinez-Gonzalez, Loreto Martinez Gonzalez, Loreto Martinez-Gonzalez, Loreto Martinez-González, Loreto Martinez‐Gonzalez, Loreto Martínez González, Loreto Martínez-Gonzalez, Loreto Martínez-González, Loreto Martínez‐González, Martinez-González, Loreto

Publications

717

Citations

H-Index

Concepts

All Affiliations

Centro de Investigaciones Biológicas Margarita Salas Biomedical Research Networking Center on Neurodegenerative Diseases Instituto de Salud Carlos III Centro de Investigación Biomédica en Red Universidad Complutense de Madrid

About

Loreto Martínez‐González is an author at Centro de Investigaciones Biológicas Margarita Salas specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	167
2	Biochemistry	4	4	94
3	Natural Sciences	3	3	58
4	Cell Biology	2	2	73
5	Chemical Biology	2	2	38

Loreto Martínez‐González

Publications

653

Citations

H-Index

Page 1

	Year	Citations
Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Journal of Medicinal Chemistry	2018	102
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment Loreto Martínez‐González, Carmen Rodríguez‐Cueto, Diego Cabezudo, Scientific Reports	2020	63
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Loreto Martínez‐González, Claudia Gonzalo‐Consuegra, Marta Gómez‐Almería, International Journal of Molecular Sciences	2021	55
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease Rita Maria Concetta Di Martino, Letizia Pruccoli, Alessandra Bisi, ACS Chemical Neuroscience	2020	48
Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis Elisa Rojas‐Prats, Loreto Martínez‐González, Claudia Gonzalo‐Consuegra, European Journal of Medicinal Chemistry Amyotrophic Lateral SclerosisNuclear Protein Tdp-43Cell DeathNeurochemical BiomarkersCell Division Cycle	2020	46
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy Vanesa Nozal, Loreto Martínez‐González, Marta Gómez‐Almería, Journal of Medicinal Chemistry	2022	40
Development of Blood–Brain Barrier Permeable Nitrocatechol-Based Catechol<i>O</i>-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity Tiago Silva, Tarek Mohamed, Arash Shakeri, Journal of Medicinal Chemistry	2016	37
Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome Alicia Mansilla, Antonio Chaves-Sanjuán, Nuria E. Campillo, Proceedings of the National Academy of Sciences	2017	37
Potential anti-Alzheimer effects of selected Lamiaceae plants through polypharmacology on glycogen synthase kinase-3β, β-secretase, and casein kinase 1δ Perihan Gürbüz, Ana Martı́nez, Concepción Pérez, Industrial Crops and Products Glycogen SynthaseAlzheimer's DiseaseBiochemistryMedicineCasein Kinase 1δ	2019	36
Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease Eliška Kohelová, Rozálie Peřinová, Negar Maafi, Molecules	2019	27

Page 1